SRTS - Sensus Healthcare Inc Stock Price, Fair Value and News

$4.00-0.06 (-1.48%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SRTS Price Action

Last 7 days

-2.7%

Last 30 days

29.0%

Last 90 days

25.8%

Trailing 12 Months

-53.4%

SRTS RSI Chart

SRTS Valuation

Market Cap

65.7M

Price/Earnings (Trailing)

-21.86

Price/Sales (Trailing)

1.85

EV/EBITDA

-7.81

Price/Free Cashflow

30.32

SRTS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SRTS Fundamentals

SRTS Revenue

Revenue (TTM)

35.6M

Rev. Growth (Yr)

-22.12%

Rev. Growth (Qtr)

-5.89%

SRTS Earnings

Earnings (TTM)

-3.0M

Earnings Growth (Yr)

-177.61%

Earnings Growth (Qtr)

9.06%

SRTS Profitability

Operating Margin

68.46%

EBT Margin

-13.13%

Return on Equity

-5.87%

Return on Assets

-5.16%

Free Cashflow Yield

3.3%

SRTS Investor Care

Shares Dilution (1Y)

0.21%

Diluted EPS (TTM)

-0.18

SRTS Alerts

2 major insider buys recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	39.5M	37.6M	35.6M	0
2024	31.7M	36.4M	41.3M	41.8M
2023	37.6M	30.1M	24.9M	24.4M
2022	31.4M	35.8M	40.2M	44.5M
2021	11.0M	0	0	27.0M
2020	23.5M	17.2M	13.0M	9.6M
2019	25.9M	27.3M	26.8M	27.3M
2018	22.2M	23.3M	24.8M	26.4M
2017	16.1M	17.5M	19.0M	20.6M
2016	11.4M	12.5M	13.7M	14.8M
2015	0	0	0	10.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About Sensus Healthcare Inc

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

CEO	Mr. Joseph C. Sardano
WEBSITE	sensushealthcare.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	42

Sensus Healthcare Inc Frequently Asked Questions

What is the ticker symbol for Sensus Healthcare Inc? What does SRTS stand for in stocks?

SRTS is the stock ticker symbol of Sensus Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sensus Healthcare Inc (SRTS)?

As of Wed Dec 03 2025, market cap of Sensus Healthcare Inc is 65.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SRTS stock?

You can check SRTS's fair value in chart for subscribers.

Is Sensus Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether SRTS is over valued or under valued. Whether Sensus Healthcare Inc is cheap or expensive depends on the assumptions which impact Sensus Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SRTS.

What is Sensus Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, SRTS's PE ratio (Price to Earnings) is -21.86 and Price to Sales (PS) ratio is 1.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SRTS PE ratio will change depending on the future growth rate expectations of investors.